Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-30 @ 9:29 AM
Study NCT ID:
NCT01430260
Status:
COMPLETED
Last Update Posted:
2012-09-06
First Post:
2011-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Omnaris Versus Levocetirizine Phase 4 Study
Sponsor:
Handok Inc.
Organization:
Study Overview
Official Title:
A Multi-center, Open, Randomized, Three-arm, Parallel-group, Phase IV Study to Compare the Efficacy of Ciclesonide Nasal Spray and Levocetirizine, Alone and in Combination for the Patient With Allergic Rhinitis
Status:
COMPLETED
Status Verified Date:
2012-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This i a comparison of the efficacy ciclesonide nasal spray and levocetirizine, alone and in combination.
Detailed Description:
randomized, open-label, three arm, parallel group, multi-center study
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: